Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Discover how Methylselenocysteine (MSC) enhances SN-38 cancer drug effectiveness through Chk2 phosphorylation and Cdc6 down-regulation.